Background: Modern oncology has a compelling problem in predicting the hazards of
venous thromboembolism (VTE) linked with chemotherapy. Although thromboprophylaxis is …

Purpose Assessment of individual VTE risk in cancer patients prior to chemotherapy is
critical for determining necessity of interventions. Risk assessment models (RAM) are …

In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous
thromboembolism is not recommended. Several risk prediction scores to identify cancer …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

Aim: We performed a systematic review and meta-analysis to provide high-level evidence on
the performance of the Khorana score in predicting VTE in patients with different types of …

Abstract Background Risk assessment models (RAMs) are relevant approaches to identify
cancer outpatients at high risk of venous thromboembolism (VTE). Among the proposed …

Aims This meta-analysis was conducted to evaluate the validity of the Caprini venous
thromboembolism (VTE) risk assessment scale in predicting the risk of VTE in inpatients with …

Background The Khorana score was developed to predict the risk of venous
thromboembolism (VTE) in cancer patients receiving chemotherapy. However, the utility of …

Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk
assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to …

Background Venous thromboembolism (VTE) is a leading cause of death among patients
with cancer. Outpatients with cancer should be periodically assessed for VTE risk, for which …